Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE in Chinese Patients with Hemophilia A
NCT02170402Phase 4Completed
- Sponsor
- Takeda
- Start
- Jun 2014
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Jun 2014; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02170402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170402.